Results from the EARLY TAVR trial — the first randomized, controlled FDA pivotal study designed to determine the best ...

Wandercraft announced today that it enrolled the first participants in a clinical trial evaluating its Personal Exoskeleton ...

JenaValve today announced new results from an expanded cohort receiving its Trilogy transcatheter heart valve (THV) system.

MiRus announced that it launched a U.S. multi-center early feasibility study for its Siegel transcatheter heart valve (THV).

Boston Scientific received FDA clearance for its Bolt intravascular lithotripsy (IVL) system, according to the FDA's 510(k) ...

Abbott (NYSE: ABT) today announced data demonstrating substantial, sustained improvements with its TriClip system.

Boston Scientific (NYSE: BSX) announced new study findings demonstrating the superiority of its Farapulse pulsed field ...

Medtronic says its Evolut TAVR shows strong valve performance and durable outcomes at 5 years in low-risk aortic stenosis ...

Johnson & Johnson MedTech says Dualto is the first and only surgical energy system to be made available in double ...

Supira Medical announced today that it completed an oversubscribed Series E financing round, bringing in $120 million.

Trump and RFK Jr. plan to cut thousands of employees from the FDA and other HHS agencies through the DOGE initiative led by ...

The Volt PFA system. [Image courtesy of Abbott] Abbott (NYSE: ABT) + announced it received CE mark approval in Europe for its ...